Molecular Partners AG
MOLN | NASDAQ
$3.58
+$0.05 (+1.42%)
At close: Oct 30, 2026, 4:00 PM ET
$3.08
-$0.50 (-13.97%)
Pre-market:
Nov 2, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | 4.97M | 7.04M | 189.56M | 9.33M | 9.34M |
Cost of Revenue | 2.05M | 47.5M | 47.84M | 50.75M | 55.72M | 56.08M |
Gross Profit | -2.05M | -42.53M | -40.81M | 138.81M | -46.39M | -46.73M |
Operating Income | -58.12M | -61.22M | -61.11M | 116.61M | -63.42M | -58.33M |
Interest Income | 1.52M | 3.38M | 4.28M | 1.2M | 108.28K | 391K |
Pretax Income | -61.65M | -54.04M | -61.98M | 117.85M | -63.78M | -62.78M |
Net Income | -61.65M | -54.04M | -61.98M | 117.85M | -63.79M | -62.76M |
Selling & General & Admin | 14.87M | 17.16M | 19M | 21.82M | 16.91M | 11.03M |
Research & Development | 40.19M | 48.6M | 48.78M | 50.75M | 55.72M | 56.08M |
Other Expenses | -4.17M | -47.09M | -47.48M | 372K | 125K | 568K |
Operating Expenses | 50.89M | 18.68M | 20.3M | 72.94M | 72.75M | 67.67M |
Interest Expense | 18K | 25K | 49K | 648.12K | 608.14K | 323.88K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 58.12M | 66.19M | 68.15M | 72.94M | 72.75M | 67.67M |
Income Tax Expense | 2K | 2K | n/a | n/a | 2K | -11K |
Shares Outstanding (Basic) | 37.27M | 34.03M | 32.77M | 32.47M | 31.01M | 25M |
Shares Outstanding (Diluted) | 37.27M | 34.03M | 32.77M | 33.27M | 31.01M | 25M |
EPS (Basic) | -1.65 | -1.59 | -1.89 | 3.63 | -2.06 | -2.51 |
EPS (Diluted) | -1.65 | -1.59 | -1.89 | 3.54 | -2.06 | -2.51 |
EBITDA | -59.49M | -51.65M | -59.52M | 119M | -60.66M | -59.58M |
EBIT | -61.63M | -54.02M | -61.95M | 116.61M | -63.23M | -62.47M |
Depreciation & Amortization | 2.14M | 2.37M | 2.42M | 2.39M | 2.57M | 2.89M |
Add to Watchlist
Select watchlists to add or remove MOLN